500 related articles for article (PubMed ID: 12598410)
41. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
[TBL] [Abstract][Full Text] [Related]
42. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
Delgado M; Reduta A; Sharma V; Ganea D
J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
[TBL] [Abstract][Full Text] [Related]
43. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
44. alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line.
Berlioz F; Maoret JJ; Paris H; Laburthe M; Farinotti R; Rozé C
J Pharmacol Exp Ther; 2000 Aug; 294(2):466-72. PubMed ID: 10900220
[TBL] [Abstract][Full Text] [Related]
45. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.
Neumann J; Bruch M; Gebauer S; Brandsch M
Eur J Biochem; 2004 May; 271(10):2012-7. PubMed ID: 15128310
[TBL] [Abstract][Full Text] [Related]
46. Intestinal dipeptide absorption is preserved during thermal injury and cytokine treatment.
Foster DR; Gonzales JP; Amidon GL; Welage LS
JPEN J Parenter Enteral Nutr; 2009; 33(5):520-8. PubMed ID: 19443858
[TBL] [Abstract][Full Text] [Related]
47. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.
Vacas E; Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Schally AV; Prieto JC; Carmena MJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1676-85. PubMed ID: 22728770
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
Thwaites DT; Cavet M; Hirst BH; Simmons NL
Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
[TBL] [Abstract][Full Text] [Related]
49. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
Nicole P; Lins L; Rouyer-Fessard C; Drouot C; Fulcrand P; Thomas A; Couvineau A; Martinez J; Brasseur R; Laburthe M
J Biol Chem; 2000 Aug; 275(31):24003-12. PubMed ID: 10801840
[TBL] [Abstract][Full Text] [Related]
50. Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line.
Nielsen CU; Amstrup J; Steffansen B; Frokjaer S; Brodin B
Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G191-9. PubMed ID: 11408272
[TBL] [Abstract][Full Text] [Related]
51. Glucose-dependent insulinotropic polypeptide-mediated signaling pathways enhance apical PepT1 expression in intestinal epithelial cells.
Coon SD; Rajendran VM; Schwartz JH; Singh SK
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(1):G56-62. PubMed ID: 25377315
[TBL] [Abstract][Full Text] [Related]
52. Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
J Biol Chem; 1993 Apr; 268(11):7640-2. PubMed ID: 8463293
[TBL] [Abstract][Full Text] [Related]
53. H(+)/solute-induced intracellular acidification leads to selective activation of apical Na(+)/H(+) exchange in human intestinal epithelial cells.
Thwaites DT; Ford D; Glanville M; Simmons NL
J Clin Invest; 1999 Sep; 104(5):629-35. PubMed ID: 10487777
[TBL] [Abstract][Full Text] [Related]
54. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner.
Alshafie W; Chappe FG; Li M; Anini Y; Chappe VM
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C107-19. PubMed ID: 24788249
[TBL] [Abstract][Full Text] [Related]
55. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
Mol Pharmacol; 1999 Dec; 56(6):1280-7. PubMed ID: 10570056
[TBL] [Abstract][Full Text] [Related]
56. Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers.
Foster DR; Landowski CP; Zheng X; Amidon GL; Welage LS
Pharmacol Res; 2009 Mar; 59(3):215-20. PubMed ID: 19084598
[TBL] [Abstract][Full Text] [Related]
57. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
Han HK; Rhie JK; Oh DM; Saito G; Hsu CP; Stewart BH; Amidon GL
J Pharm Sci; 1999 Mar; 88(3):347-50. PubMed ID: 10052994
[TBL] [Abstract][Full Text] [Related]
58. Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism.
Bleasby K; Chauhan S; Brown CD
Br J Pharmacol; 2000 Feb; 129(3):619-25. PubMed ID: 10711363
[TBL] [Abstract][Full Text] [Related]
59. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
[TBL] [Abstract][Full Text] [Related]
60. Substrate upregulation of the human small intestinal peptide transporter, hPepT1.
Walker D; Thwaites DT; Simmons NL; Gilbert HJ; Hirst BH
J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):697-706. PubMed ID: 9508831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
